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Previous studies have demonstrated 1) that patterns of 
inducible endothelial cell expression of endothelial 
leukocyte adhesion molecule-l (ELAM-l) and vascular 
cell adhesion molecule-l (VCAM-l) in response to cy-
tokines varies both with anatomic position within the 
dermal microvasculature and with the presence of 
perivascular inflammatory infiltrates, and 2) that the 
anatomic architecture of the dermal superficial plexus 
(SVP) is altered in inflamed lesional but not in uni-
volved skin of psoriatic patients. The present study was 
designed to evaluate the pattern of cytokine inducibi-
lity ofELAM-l and VCAM-l in altered dermal micro-
vessels of psoriatic patients. At the light microscope 
level, preculture biopsies of uninvolved and perile-
sional skin were indistinguishable by morphology and 
ELAM-l and VCAM-l expression were virtually ab-
sent. In contrast, biopsied lesional skin showed elon-
gated capillary loops and increased numbers ofT cells 
compared to uninvolved and perilesional skin. The 
dermal microvasculature of the SVP of lesional skin 
contained ELAM-l+ in 29.4% of vessels and VCAM-l+ 
endothelial cells in 8.7% of vessels. After 24 h of organ 
culture in medium supplemented with tumor necrosis 
factor and interleukin-4, ELAM-l + endothelial cells in 
M icrovascular endothelial cells of human skin con-tribute to the recruitment of inflammatory leuko-cytes by expressing inducible leukocyte adhesion molecules such as endothelial leukocyte adhesion molecule-1 (ELAM-l, also called E-selectin) , vas-
cular cell adhesion molecule-1 (VCAM-1), and intercell ular adhe-
sion molecule-l (ICAM-1 , also called CD54). ELAM- l appears 
particularly important in the recruitment of neutrophils and may 
also participate in recruitment of other leukocytes such as inflam-
matory T cell s and monocytes [1,2]. VCAM-l contributes to selec-
tive recruitment of T cells and eosinophils but not neutrophils 
[1 ,3,4]. Elevated ICAM-1 also appears more closely associated with 
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the SVP were increased significantly in uninvolved 
(from mean 0.5% to 27% of vessels), perilesional (from 
mean 5.5% to 41.8% of vessels), and lesional skin (from 
mean 29.4% to 45.7% of vessels) . VCAM-l was not in-
ducible on SVP endothelial cells in uninvolved skin 
but VCAM-l+ endothelial cells were increased signifi-
cantly in perilesional (from mean 0.7% to 23.7% of 
vessels) and lesional skin (from mean 8.7% to 41.4% of 
vessels). In uninvolved and perilesional skin ELAM-l 
and VCAM-l were confined to endothelial cells below 
the rete. In contrast, endothelial cells of the intrapapil-
lary part of the capillary loop oflesional skin became 
cytokine responsive, in that ELAM-l and VCAM-l 
could be induced at this site. By immunoelectron mi-
croscopy, expression was most intense on the luminal 
surface of venular endothelial cells and at the inter en-
dothelial junctions. In conclusion, we have presented 
evidence that the cytokine responsiveness of microvas-
cular endothelial cells is altered in psoriasis in a pattern 
that may explain both the circumscribed nature and 
the epidermal involvement of the psoriatic plaque. Key 
words: ELAM-1 / VCAM-1 / organ culture/ superficial vascu-
lar plexus.] Invest DermatoI103:300-305, 1994 
T-cell infiltration ill lIillo [5,6]' but also contributes to neutrophil 
adhesion and transmigration in vitro [1,7]. I " vivo as well as cell and 
organ-culture experiments have identified inflammatory cytokines, 
including interleukin (IL)-l, tumor necrosis factor (TNF), inter-
feron (IFN)-y, and IL-4, as the major signals that induce the expres-
sion of these adhesion mo lecules [8 - 15]. Furthermore, skin organ-
culture experiments have revealed that the responsiveness of 
microvascular endothelial cells to cytokines varies with anatomic 
position. Specifically, in the superficial vascular plexus (SVP), 
inducible ELAM-1 expression is largely confined to the venules of 
the horizontal plexus and the venular portions of the capillary 
loops, i.e. , that portion below the level of the rete just proxi-
mal to anastomosis with the horizontal vessels [15]. TNF and IL-l 
are the most potent signals for induction ofELAM-l. VCAM-l , in 
normal skin, is not inducible on endothelial cells of the SVP by any 
combination of cytokines and its expression is confined largely to 
vessels of the deep vascular plexus. In organ-cultured acutely in-
flamed skin, ELAM-l is basally expressed and VCAM-l becomes 
inducible on SVP venular endothelial cells by a combination 
of TNF and IL-4. Even in dermatitis, these adhesion molecules 
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cannot be induced on the intrapapillary parts of the capillary loops 
[1 ?fhe architecture of the SVP is altered in psoriasis. Specifically, 
the capillary loops of lesional skin are tortuous and elongated [16] 
and the normally well-defined boundary between capillary endo-
thelial cells resting on an arteriolar-like homogeneous basement 
membrane and endothelial cells on a venular-like laminated base-
ment membrane are aberrant [17]. Microvascular endothelial cells 
in lesional psoriatic skin express both ELAM-1 and VCAM-1 mole-
cules [10,18], but the anatomic distributions and cytokine respon-
siveness of altered psoriatic microvessels have not previously been 
described. In addition, the evaluation of perilesional microvessels 
presents the opportu~ity ~o sepa~at~ the contributio~s of primary 
microvascular alteratlOllS 111 psonasls from those of 1I1flammation 
observed in lesional vessels. 
MATERIALS AND METHODS 
skin Specimens Trunk skin of eight different psoriatic patients, ranging 
in age from 40 to 60 years, was obtained according to a protocol approved by 
the Yale Human Investigations Committee. Superficial 3-mm punch biop-
sies were taken from lesional skin (n = 7; six with plaque-type and one with 
guttate psoriasis), from normal~appearing skin at a 5- to 10-mm distance 
from the leSion (penleslOnal skill, n = 8), and from chlllcally umnvolved 
skin at sites at least 50 mm away from the nearest lesion (uninvolved skin, 
n =4). 
Skin Organ Culture Each punch biopsy was bisected perpendicular to 
the epidermis. One part was immediately embedded in OCT (Miles, Naper-
ville, IL), snap frozen, and stored at -70 ' C. The other half was placed in 
skin organ cultures as described previously [15]. In brief, skin specimens 
were placed in C24-well plates (Falcon, Bedford, MA) with the epidermis 
facing up, and attached to the plastic by air drying. RPMI 1640 culture 
medium (Gibco, Grand Island, NY) supplemented with 10% human AB 
serum (vol/vol; Gibco), L-glutamine (10 mM; Gibco), penicillin (100 U/ 
rnl; Gibco), streptomycin (100 ,ug/ml; Gibco), recombinant TNF, 200 U/ 
mI, obtained from Biogen (Cambridge, MA), and recombinant IL-4, 2000 
V/ml, obtained from Schering Plough Research (Bloomfield, NJ) was gen-
tly added to each well so that just the epidermis remained uncovered. This 
combination and dosage of cytokines was identified previously as that pro-
ducing maximal changes in VCAM-l expression on dermal microvascular 
endothelial cells (DMECs) in organ culture [15]. Explants were incubated at 
37" C in humidified CO2/95% air for 24 h. At the end of the incubation 
period, explants were embedded in OCT and snap frozen. 
Monoclonal Antibodies (MoAbs) and Lectins The following mouse 
MoAbs wereIgG1 isotypes: anti - ELAM-1 (H4/18), anti- VCAM-1 (E1/6; 
gift of M .P. Bevilacqua, Universiry of California at San Diego, San Diego, 
CAl, anti-CD36 {OKM-5; Ortho, Raritan, NJ, and non-binding control 
(K16/16; gift of D.L. Mendrick, Brigham and Women's Hospital, Boston, 
MA) . Mouse anti-human CD3, COla, and CD68 MoAbs were IgG2a iso-
types and obtained from Dakopatts (Carpinteria, CAl. Ulex europells agglu-
tinin I {UEA I)-biotin was purchased from Vector Labs (Burlingame, CAl. 
Inununohistochemistry Four-micrometer sections were processed and 
double-stained as described [15]. In brief, the first MoAb {H4/18, El/6, or 
OKM-5} was visualized using the alkaline phosphatase anti-alkaline phos-
phatase (APAAP) technique and stained in blue by the alkaline phospatase 
substrate kit obtained from Vector. The biotinylatcd lectin UEA I was visu-
alized using peroxidase-labeled avidin-biotin complexes and stained in red 
by 3-amino-9-ethylcarbazole (Sigma Chemical Co., St. Louis, MO). Con-
trols were performed by using a non-binding control MoAb (K16/16) as a 
first-step reagent and/or by omitting the lectin. For CDla, CD3, or CD68 
antigens, single antibody staining was performed using the peroxidase Vec-
taStain ABC kit (Vector). 
Scoring and Statistical Analysis CD36, ELAM-l and VCAM-l ex-
pression on endothelial cells were quantified on sections double stained with 
UEA I as described [15] . The total number of vascular profiles (as identified 
by UEA I staining) within the superficial vascular plexus (SVP) was deter-
mined in four randomly selected high-power fields in two different sec-
tions/skin specimens and then the number of CD36-, ELAM-1 - , and 
VCAM-l-positive vessels were determined in the same fields. Vessels of the 
deep vascular plexus were excluded because the deeper portions of the 
dermis were usually not present in the biopsy specimens. Vessel cross-sec-
tions were considered to be positively stained when at least one cell in the 
cross-section was clearly reactive with the specific MoAb. Staining intensity 
was not considered. Data are expressed as the percentage of the total vessels 
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Figure 1. Percentage of ELAM-l+ or VCAM-l+ SVP vessel cross-
sections in uninvolved, perilesional, and lesional psoriatic skin. Each 
liue connects preculture valu.es (left). with the percentage of positive vessels 
after 24 h of organ culture 111 medium supplemented with TNF and IL-4 
(right) of an individual skin specimen evaluated as described in Materials OIld 
Methods. The numbers to the right of the figure indicate the densities of 
CI?3+ cells within the papillary dermis for uninvolved , perivascular, or 
leslOual skill pnor to culture. Although VCAM-l expression is significantly 
II1duclble III organ-cultured penleslOnal skin, the density of dermal T cells in 
perilesional skin is comparable to that seen in uninvolved skin. 
(UEA 1+) in the SVP showing C D36 , ELAM-I, or VCAM-l expression . 
Num~ers of T+ cells were quantified in the preculture skin specimen by 
countlllg CD3 cells I~ four lugh-power fields (HPF; 0.5 mm in diameter) 
wlthlll the upper dernus Il1 two different sections and the mean densiry / HPF 
was detenlll~l~d. All specllnens were scored by a single observer (PP) blinded 
to the conditIOns .. The interobserver correlation coefficient (R2) has been 
preVIOusly determllled as being 0.95 [15]. Data were pooled for each rype of 
specimen {lesional , perilesional , or normal skin} and for each MoAb, and are 
presented as mean ± SEM. Statistics were performed using the Student t test. 
Immunoelectron Microscopy The organ-culture specimens were hand 
cut into approximately 100-lim sections and fixed by immersion in 30/0 
paraformaldehyde in 0.1 M phosphate buffer, pH 7.4, for 2 h at 4 ' C , 
followed by rinsing in phosphate buffer for 1 h. Immunohistochemistry was 
performed using the peroxidase Vectastain ABC kit (Vector) . The sections 
were incubated with the prima.ry MoAbs (H4/ 18 and E1/ 6) overnight at 
4 ' C and the reaction products were visualized with diaminobezidine 
(Sigma). Sections were post-fixed with half-strength Karnovsky 's fixative 
and .wlth 1 % OS04 and then embedded in Spurr's epoxy res in [19). Ultrathin 
sectIOns were prepared for viewing using a Zeiss electron microscope model 
EM-l09. 
RESULTS 
Uninvolved Skin The mean density of CD3+ cells/HPF in un-
involved skin from psoriatic patients was 6.7 ± 0.6 (Fig 1), which 
302 PETZELBAUER ET AL 
is comparable to previously published CD3 counts in normal skin 
[20]. In the preculture specimens, endothelial cells did not express 
ELAM-l (0.5% ± 0.5% of vessels) or VCAM-l (0.7% ± 0.7% of 
vessels) molecules, consistent with previous reports [15,21]. The 
percentage of CD36+ vessel cross-sections within the SVP ranged 
from 15% to 25%, which is identical to that seen in normal non-
psoriatic skin specimens [15]. CD36 molecule expression was unal-
tered by the cytokine treatment used and no differences were ob-
served among uninvolved, periesional, or lesional skin specimens 
and will not be discussed further. 
When uninvolved skin was placed in organ-culture medium sup-
plemented with TNF and IL-4 for 24 h, ELAM-l expression on 
endothelial cells was significantly upregulated (27% ± 1.7% of 
vessels; p < 0.001 compared to precultured skin; Fig 1) and was 
restricted to venular endothelial cells. This extent of ELAM-l up-
regulation is comparable to that seen in normal, non-psoriatic skin 
[15]. The capillary loops within the tips of the papillae above the 
lower level of the rete ridges remained ELAM-l negative, as previ-
ously noted in normal skin [15] . VCAM-l expression on endothe-
lial cells was undetectable after 24 h of organ culture (1.5% ± 1.0% 
of vessels; Figs 1,2a), also consistent with previous findings in 
endothelial cells of the SVP in normal skin. 
Perilesional Skin At the light microscope level, perilesional skin 
was generally indistinguishable from uninvolved skin in terms of 
vascularization and density of dermal leukocytes. The rete were not 
elongated in any of the eight specimens, although the epidermis in 
two of eight specimens was slightly acanthotic. The mean density of 
CD3+ cells/HPF was 14.3 ± 6.2, difference not significant com-
pared to uninvolved skin (Fig 1). The num.bers of CD1a+ dendritic 
cells and CD68+ macrophages were also comparable to those seen in 
uninvolved skin (data not shown). Only 5.5% ± 2.3% of vessels 
contained ELAM-l + endothelial cells, difference not significant 
compared to uninvolved skin. VCAM-l expression on endothelial 
cells was virtually undetectable (0.7% ± 0.4% of vessel cross sec-
tions ·contained VCAM-l + endothelial cells). 
After 24 h of organ culture in medium supplemented with TNF 
and IL-4, ELAM-1 + endothelial cells were significantly increased to 
41.8% ± 4.2% of vessel cross-sections (p < 0.001 compared to pre-
cultured perilesional skin; Fig 1), which is similar to the findings in 
uninvolved skin. In striking contrast to uninvolved skin, VCAM-1 
expression was induced on endothelial cells in cytokine-treated per-
ilesional skin to a level of 23.7% ± 7.1 % of vessel cross-sections; 
p < 0.05 compared to precultured skin (Fig 1). The expression of 
both ELAM-l and VCAM-l (Fig 2b) was restricted to the horizon-
tal venules and the venular limb of the capillary loops below the 
level of the rete. No ELAM-1+ or VCAM-1+ endothelial cells were 
noted in the capillary loops above the level of the rete. By immu-
noelectron microscopy, staining for VCAM-1 molecules was found 
on the luminal side of the venular endothelial cells and on the 
interendothelial junctions. VCAM-l + endothelial cells could be 
detected next to VCAM-1- endothelial cells within the same mi-
crovessel. 
Lesional Skin Morphologically, lesional specimens showed epi-
dermal hyperproliferation, elongation of the rete ridges, tortuous 
elongation of the capillary loops, and a moderate perivascular round 
Figure 2. Uninvolved (a), perilesional (b), and lesional (c) psoriatic 
skin after 24 h of organ culture in medium supplemented with TNF 
and IL-4, stained immunohistochemically with anti- VCAM-l 
MoAb in blue and the panendothelial marker UEA I in red. In unin-
volved skin (a), VCAM-l cannot be induced on SVP endothelial cells; in 
pcrilesional skin (b), VCAM-l expression is found on the horizontal venules 
of the SVP (arrows). Capillary loops extending upward to the papillae are 
VCAM-l- (arrowhead). In lesional skin (e), VCAM-l expression is found on 
capillaries and small venulcs of the SVP (arrows), but also extends upward 
into the intrapapillary portion of the capillary loop (arrowhead). Bar, 
SO lim. 
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Figure 3. The proximal part of a dermal capillary loop in lesional 
psoriatic skin after 24 h of organ culture in medium supplemented 
with TNF and IL-4 shown in a i-ttm plastic section. The epidermis (E) 
is separated from the dermal papilla (P); arterial limb (A); venous limb (V). 
cell infiltrate. The mean density of dermal CD3+ cells/HPF was 
81.8 ± 24.4, which is significantly higher than in perilesional or 
uninvolved skin (p < 0.05; Fig 1). The percentage of vascular pro-
@es containing ELAM-1+ endothelial cells was 29.4% ± 6% and 
8.7% ± 3.2% contained VCAM-1+ endothelial cells (Fig 1). The 
expression of both molecules was detectable on endothelial cells in 
the venules of the SVP and in the capillary loops below the lower 
level of the rete ridges. Of note, these molecules were also expressed 
on capillary endothelial cells within the tips of the papillae in that 
part of the loop that is in close anatomical proximity to the basal 
keratinocytes. 
In lesional skin, treatment with cytokines in organ culture in-
creased ELAM-1 + endothelial cells to 45.7% ± 3.1 % of vessels; 
p < 0.05 (Fig 1). VCAM-1+ endothelial cells were further in-
creased to 41.4% ± 4.6% of vascular profiles; p < 0.005 compared 
to precultured skin (Fig 1), Again, as seen in fresh lesional skin, 
inducible ELAM-1 and VCAM-1 (Fig 2c) expression was detecta-
ble on capillary loops below and above the lower level of the rete 
ridges. Furthermore, the staining intensity appeared enhanced in 
organ-cultured skin compared to preculture specimens. Immuno-
electron microscopy confirmed the light microscopic observations. 
Within the horizontal part of the SVP ELAM-1+ and VCAM-1 
endothelial cells (Fig 2) were found to be present within venules 
but not arterioles. Immunoelectron microscopic evaluation was also 
used to localize ELAM-1 and VCAM-1 within the capillary loops. 
This is best illustrated by comparing Figs 3 and 4. Figure 3 is a 1-l1m 
plastic section of organ-cultured lesional skin showing a capillary 
loop. As seen in Fig 4, only the endothelial cells of the venular side 
of the loop characterized by a laminated basement membrane ex-
press ELAM-l molecules. 
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DISCUSSION 
We have examined the ELAM-1 and VCAM-1 expression patterns 
in uninvolved, perivascular, and lesional psoriatic skin before and 
after 24 h of organ culture in medium supplemented with TNF and 
IL-4. We found that in preculture uninvolved and in perilesional 
skin ELAM-1 and VCAM-l molecules are virtually absent on SVP 
endothelium, whereas these molecules are expressed on endothelial 
cells in lesional skin. After 24 h of cytokine treatment in organ 
culture. ELAM-l is inducible on venules in uninvolved, perile-
sional, and in lesional skin. In contrast, VCAM-1 is not inducible in 
uninvolved skin of psoriatic patients, consistent with our previous 
report on organ-cultured normal skin of non-psoriatics [15]. Unex-
pectedly, cytokine stimulation of perilesional skin causes a signifi-
cant upregulation of VCAM-1 expression on venular endothelial 
cells of the SVP, compared to the preculture specimen, which is 
comparable to the cytokine-induced upregulation ofVCAM-1 ex-
pression in organ-cultured lesional skin. Arteriolar endothelial cells 
are consistently ELAM-1 and VCAM-1 negative in all specimens. 
However, in psoriatic lesional skin, the intrapapillary portion of the 
capillary loop acquires cytokine responsiveness and is able to express 
ELAM-1 or VCAM-1 molecules. These altered cytokille responses 
parallel the elongation of the venular side of the loop characterized 
by a laminated basement membrane. 
The phenotypic change ofSVP endothelial cells consisting in the 
ability to express VCAM-1 in perilesional psoriatic skin may be 
relevant to the pathogenesis of psoriasis. VCAM-1 expression has 
been observed in SVP endothelial cells ill lIillo only in settings of 
natural or cytokine-induced inflammation [9,18,22,23J, and our 
previous organ culture experiments of inflamed skin suggested that 
the infiltrating leukocytes were necessary for endothelial cells to 
display this capacity [15]. This led us to propose that infiltrating 
leukocytes provide an as-yet unidentified co-factor that relieved 
some inhibitory constraint. The present study suggests that SVP 
endothelial cells can be relieved of this inhibition in the absence of 
infiltrating leukocytes. The basis of this change is unknown but is 
consistent with previous observations that the function of the mi-
crovasculature in perilesional psoriatic skin is altered. For example, 
there is increased blood flow in perilesional psoriatic skin in the 
absence of any microscopically detectable changes [24]. This alter-
ation in the behavior of endothelial cells only at the advancing edge 
of a psoriatic plaque may contribute to the sharply circumscribed 
character of psoriatic lesions. 
The other finding in this paper relevant for the pathogenesis of 
psoriasis involves the phenotypic alteration of the endothelial cells 
in the capillary loop in lesional skin of psoriasis that is not found in 
acute dermatitis [15]. The expression ofELAM-1 and VCAM-1 in 
this part of the capillary loop that is in proximity to the epidermis 
probably contributes to the typical histopathologic appearance of 
psoriatic lesions with epidermotropic neutrophils and T cells. 
ELAM-1 is important for neutrophil recruitment [1,2]' and thus 
expression of ELAM-1 at that site could initiate neutrophil traffic 
into the epidermis that results in the characteristic picture of 
"mounds of neutrophils on top of parakeratosis," which are typi-
cally localized above a tip of a papilla [25]. Epidermotropic T cells 
that express the ELAM-1 ligand detected with MoAb HECA 452 
(sometimes called cutaneous lymphocyte-associated antigen-1) 
could also adhere in this part of the capillary loop [26,27]. Endothe-
lial cell VCAM-1 interactions with T-cell VLA-4 may aJso contrib-
ute to epidermotropism of these cells [2]. These speculations are 
supported by adhesion assays that demonstrate the enhanced bind-
ing of leukocytes, especially CD4+ lymphocytes, to psoriatic SVP 
endothelium within the intra papillary part of the capillary loop 
[28-30]. 
In conclusion, we have presented evidence that the cytokine re-
sponsiveness of microvascular endothelial cells is a.ltered in psoriasis 
in a pattern that may explain both the circumscribed nature and the 
epidermal involvement of the psoriatic plaque. These findings also 
suggest the more general proposition that analysis of the contribu-
tion of endothelial cell adhesion molecules to inflammatory disease 
must not only take into account the presence of inflammatory cyto-
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Figure 4. Immunoelectron microscopy ofELAM-l from the section shown in Fig 3. Arterial limb with a homogenous basement membrane 
(A); venous limb with a laminated basement membrane (V); de granulated mast cells (M). Bar, 111m. Lift upper itlSct, higher magnification of the 
arterial limb indicated by the box. The endothelial cell (E) surface is negative for the peroxidase reaction product. Bar, 111m. Right upper inset, higher 
magnification of the venous limb indicated by the box and shows the endothelial cell (E) surface positive for the peroxidase reaction product. Bar, 111m. 
kines that induce these molecules but the variable abi lity of specific 
endothelial cells to respond. 
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ANNOUNCEMENT 
"The Board of the Austrian Society of Dermatology and Venereology (hoc tempore president, 
Klaus Wolff, M.D.) has awarded the Ferdinand von Hebra Medal in gold to Professor John 
Thorne Crissey, University of Southern California, Los Angeles for achievements in the his-
tory of medicine (dermatology} ." (Upon application by Karl Holubar, M.D., past president and 
historian) . 
